A-A-51384B
13 June 1990
SUPERSEDING
A-A-0051384A
25 September 1986
COMMERCIAL ITEM DESCRIPTION
NAFCILLIN SODIUM FOR INJECTION, USP
The General Services Administration has authorized the use of this Commercial Item Description.
Salient characteristics:
Shall be Nafcillin Sodium for Injection, USP.
Shall be in accordance with the requirements of the USP.
For Strength 1, each vial shall contain a quantity of Nafcillin Sodium, equivalent to 500 mg of Nafcillin within the applicable assay limits. Shall be suitable for either intramuscular or intravenous use.
For Strength 2, each vial shall contain a quantity of Nafcillin Sodium, equivalent to 1 gram of Nafcillin within the applicable assay limits. Shall be suitable for either intramuscular or intravenous use.
For Strength 3, each vial shall contain a quantity of Nafcillin Sodium, equivalent to 10 grams of Nafcillin within the applicable assay limits. Shall be suitable for either intramuscular or intravenous use.
For Strength 4, each vial shall contain a quantity of Nafcillin Sodium, equivalent to 2 grams of Nafcillin within the applicable assay limits. Shall be suitable for either intramuscular or intravenous use.
Workmanship. Product shall be free from defects which detract from its appearance or impair its serviceability.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business